Oxygen Consumption Required by Stroke Patients During Completion of the Modified Rivermead Mobility Index (MRMI)

This study has been completed.
Information provided by:
The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier:
First received: September 14, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted

The aim of this study was to measure the oxygen consumption and peak heart rate achieved during Modified Rivermead Mobility Index (MRMI) assessment in age-matched, healthy and stroke patients, and assess the efficacy of the MRMI tasks for aerobic training in patients with stroke.


Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional

Resource links provided by NLM:

Further study details as provided by The Hong Kong Polytechnic University:

Primary Outcome Measures:
  • Oxygen consumption

Subjects with normal health
Subjects with Stroke


Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Both
Sampling Method:   Non-Probability Sample
Study Population

stroke unit of local hospital and community groups


Inclusion Criteria:

  • diagnosis of hemisphere stroke
  • aged fifty or above
  • ambulatory with/ without walking aid
  • had ability to provide informed consent and understand the evaluation procedures

Exclusion Criteria:

  • brainstem and cerebellar lesion
  • unconscious or drowsy
  • musculoskeletal, respiratory or other disease that may limit activity of daily livings
  • serious cardiovascular disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00976885

Cardiopulmonary and exercise physiology laboratory, The Hong Kong Polytechnic University
Hong Kong, China
Sponsors and Collaborators
The Hong Kong Polytechnic University
  More Information

No publications provided

Responsible Party: Alice YM Jones, The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier: NCT00976885     History of Changes
Other Study ID Numbers: HSEARS20090209006
Study First Received: September 14, 2009
Last Updated: September 14, 2009
Health Authority: Hong Kong: Ethics Committee

Additional relevant MeSH terms:
Cerebral Infarction
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Brain Infarction
Brain Ischemia

ClinicalTrials.gov processed this record on April 16, 2014